PhysioMimix
Provider 
Founded 2008
Sells To Pharmaceutical Manufacturers, Researchers
Pricing Model Product Sales, Service Fees
Ownership Venture-backed

PhysioMimix is CN Bio's organ-on-a-chip microphysiological system for preclinical drug discovery.
PhysioMimix is CN Bio's microphysiological system that recreates human organ and tissue function in vitro using perfused primary-cell models. Researchers use the benchtop PhysioMimix Core system with single-organ, multi-organ and higher-throughput configurations to generate human-translatable efficacy, ADME and safety data.
The platform covers liver, lung, gut-liver and kidney models for applications such as drug-induced liver injury, bioavailability and metabolic disease studies, and is positioned as an alternative to animal testing in preclinical drug development.
Emulate

AVA Emulation System, Brain-Chip R1, Zoë-CM2 Culture Module
emulatebio.com
Nortis

ParVivo Platform
nortisbio.com
| Attribute | PhysioMimix | AVA Emulation System, Brain-Chip R1, Zoë-CM2 Culture Module | ParVivo Platform | |
|---|---|---|---|---|
| Provider | ||||
| Founded | 2008 | 2013 | 2007 | |
| Sells To | Pharmaceutical Manufacturers, Researchers | Enterprise, Government | Enterprise | |
| Pricing Model | Product Sales, Service Fees | Recurring, Software, Transactional | Recurring | |
| Ownership | Venture-backed | Private, Venture-backed | Venture-backed |
Provider 
Founded 2008
Sells To Pharmaceutical Manufacturers, Researchers
Pricing Model Product Sales, Service Fees
Ownership Venture-backed
Provider 
Founded 2013
Sells To Enterprise, Government
Pricing Model Recurring, Software, Transactional
Ownership Private, Venture-backed
Provider 
Founded 2007
Sells To Enterprise
Pricing Model Recurring
Ownership Venture-backed


Emulate Organ-Chip Platform is an organ-on-a-chip system for human-relevant preclinical drug testing.


OrganoPlate Platform is MIMETAS's high-throughput organ-on-a-chip system for 3D human tissue models.


OrganoReady is MIMETAS' ready-to-use Assay Ready tissue model product line for organ-on-a-chip drug testing.


OrganoPlate is a mass-produced organ-on-a-chip microfluidic platform for 3D human tissue and disease modeling in drug discovery.


MIMETAS provides contract research services building custom organ-on-a-chip disease models and assays for pharmaceutical drug discovery.
Emulate Organ-Chip Platform is an organ-on-a-chip system for human-relevant preclinical drug testing.

OrganoPlate Platform is MIMETAS's high-throughput organ-on-a-chip system for 3D human tissue models.

OrganoReady is MIMETAS' ready-to-use Assay Ready tissue model product line for organ-on-a-chip drug testing.

OrganoPlate is a mass-produced organ-on-a-chip microfluidic platform for 3D human tissue and disease modeling in drug discovery.

MIMETAS provides contract research services building custom organ-on-a-chip disease models and assays for pharmaceutical drug discovery.
